ClinicalTrials.Veeva

Menu

Prevalence of Primary Aldosteronism in Patients With Stroke

C

Changi General Hospital

Status

Completed

Conditions

Stroke
Primary Aldosteronism

Treatments

Diagnostic Test: Aldosterone renin ratio

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Strokes leads to significant morbidity and mortality, and hypertension is the most important risk factor for strokes. It is estimated that up to 10% of patients with hypertension have the underlying, treatable condition of primary aldosteronism. Hence, we hypothesize that the prevalence of primary aldosteronism is high in patients with strokes, a complication of long-standing hypertension.

Patients admitted with an acute stroke to the Acute Stroke Unit, Changi General Hospital, will be screened for Primary Aldosteronism three months post-stroke, and confirmatory tests will be done with saline-infusion test.

Enrollment

300 patients

Sex

All

Ages

21 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 21-80 years
  2. Admitted with acute cerebrovascular accident (CVA) or transient ischemic attack (TIA) to the ASU, CGH
  3. Patients with both ischemic and hemorrhagic strokes

Exclusion criteria

a. Pregnant patients

Trial design

300 participants in 1 patient group

Single Arm
Description:
All patients admitted to the Acute Stroke Unit
Treatment:
Diagnostic Test: Aldosterone renin ratio

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems